Leptospirosis-persistence of a dilemma: An overview with particular emphasis on trends and recent advances in vaccines and vaccination strategies

Pakistan Journal of Biological Sciences

Volumn 15, Issue 20, 2012, Pages 954-963

  Verma, Amit Kumar ^a   Kumar, Amit ^a   Dhama, K ^b   Deb, Rajib ^c   Rahal, Anu ^a   Mahima, ^a   Chakraborty, Sandip ^a  

^a UP Pandit DDayal Upadhayay Pashu Chikitsa Vigyan Vishvidhyalaya Ewam Go Anusandhan Sansthan DUVASU ^*  (India)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^c INDIAN COUNCIL OF AGRICULTURAL RESEARCH   (India)

Author keywords

DNA vaccine; Killed vaccine; Leptospira; Leptospirosis; Protein antigen; Proteomics; Recombinant vaccine; Reverse genetics; Serovar; Vaccine

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN G;

ANIMAL; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; LEPTOSPIROSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; LEPTOSPIROSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84874882006     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2012.954.963     Document Type: Review

References (93)

1. Abela-Ridder, B., R. Sikkema and R.A. Hartskeerl, 2010. Estimating the burden of human leptospirosis. Int. J. Antimicrob. Agents, 36: S5-S7.
2. Adler, B. and A. de la Pena Moctezuma, 2010. Leptospira and leptospirosis. Vet. Microbiol., 140: 287-296.
3. Amilasan, A.S.T., M. Ujiie, M. Suzuki, E. Salva and M.C.P. Belo et al., 2012. Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg. Infect. Dis., 18: 91-94.
4. Arent, Z.J., S. Andrews, K. Adamama-Moraitou, C. Gilmore, D. Pardali and W.A. Ellis, 2012. Emergence of novel Leptospira serovars: A need for adjusting vaccination policies for dogs? Epidemiol. Infect., (In Press). 10.1017/S0950268812002087
5. Artiushin, S., J.F. Timoney, J. Nally and A. Verma, 2004. Host-inducible immunogenic sphingomyelinase-like protein, Lk73.5, of Leptospira interrogans. Infect. Immunity, 72: 742-749.
6. Atzingen, M.V., M.L. Vieira, R. Oliveira, R.F. Domingos and R.S. Mendes et al., 2012. Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis. Open Microbiol. J., 6: 79-87.
7. Balassiano, I.T., J.M. Vital-Brazil and M.M. Pereira, 2012. Leptospirosis diagnosis by immunocapture polymerase chain reaction: A new tool for early diagnosis and epidemiologic surveillance. Diagn. Microbiol. Infect. Dis., 74: 11-15.
8. Branger, C., B. Chatrenet, A. Gauvrit, F. Aviat, A. Aubert, J.M. Bach and G. Andre-Fontaine, 2005. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein. Infect. Immun., 73: 4062-4069.
9. Branger, C., C. Sonrier, B. Chatrenet, B. Klonjkowski and N. Ruvoen-Clouet et al., 2001. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect. Immun., 69: 6831-6838.
10. Brett-Major, D.M. and R. Coldren, 2012. Antibiotics for leptospirosis. Cochrane Database Syst. Rev., 10.1002/14651858. CD008264. pub2
11. Brown, R.A., S. Blumerman, C. Gay, C. Bolin, R. Duby and C.L. Baldwin, 2003. Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo. Vaccine, 21: 4448-4458.
12. Caimi, K., V. Varni, Y. Melendez, A. Koval, B. Brihuega and P. Ruybal, 2012. A combined approach of VNTR and MLST analysis: Improving molecular typing of Argentinean isolates of Leptospira interrogans. Mem. Inst. Oswaldo Cruz., 107: 644-651.
13. Chapman, A.J., S. Faine and B. Adler, 1990. Antigens recognized by the human immune response to vaccination with a bivalent hardjo/pomona leptospiral vaccine. FEMS Microbiol. Immunol., 2: 111-118.
14. Coutinho, M.L., H.A. Choy, M.M. Kelley, J. Matsunaga and J.T. Babbitt et al., 2011. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLOS Negl. Trop. Dis., Vol. 5. 10.1371/journal. pntd.0001422
15. Cullen, P.A., D.A. Haake, D.M. Bulach, R.L. Zuerner and B. Adler, 2003. LipL21 is a novel surface-exposed lipoprotein of pathogenicLeptospira species. Infect. Immun., 71: 2414-2421.
16. Dai, B., Z. You, P. He, M. Wang and Y. Wang, 2003. Analysis of CpG motifs in endoflagellar gene (flaB2) and expression vector (VR1012) of leptospiral DNA vaccine. Sichuan Da Xue Xue Bao Yi Xue Ban, 34: 1-4.
17. Deb, R., S. Chakraborty, U. Singh, S. Kumar and A. Sharma, 2012. Leptospiroisis. In: Infectious Disease of Cattle, Deb, R. (Ed.). Satish Serial Publishing House, Delhi, India, pp: 37-41.
18. Dechet, A.M., M. Parsons, M. Rambaran, P. Mohamed-Rambaran and A. Florendo-Cumbermack et al., 2012. Leptospirosis outbreak following severe flooding: A rapid assessment and mass prophylaxis campaign; Guyana, January-February 2005. PLoS One, Vol. 7. 10.1371/journal. pone.0039672
19. Dellagostin, O.A., A.A. Grassmann, D.D. Hartwig, S.R. Felix, E.F. da Silva and A.J. McBride, 2011. Recombinant vaccines against leptospirosis. Human Vaccin., 7: 1215-1224.
20. Diament, D., M.K. Brunialti, E.C. Romero, E.G. Kallas and R. Salomao, 2002. Peripheral blood mononuclear cell activation induced byLeptospira interrogans glycolipoprotein. Infect. Immun., 70: 1677-1683.
21. Djelouadji, Z., V. Roux, D. Raoult, A. Kodjo and M. Drancourt, 2012. Rapid MALDI-TOF mass spectrometry identification of Leptospiraorganisms. Vet. Microbiol., 158: 142-146.
22. Dzupova, O., D. Smiskova, Z. Huzova and J. Benes, 2012. Leptospirosis contracted from pet rats. Klin Mikrobiol Infekc Lek., 18: 156-159.
23. Ellis, W.A., 2010. Control of canine leptospirosis in Europe: Time for a change? Vet. Rec., 167: 602-605.
24. Felix, S.R., D.D. Hartwig, A.P. Argondizzo, E.F. Silva and F.K. Seixas et al., 2011. Subunit approach to evaluation of the immune protective potential of leptospiral antigens. Clin. Vaccine Immunol., 18: 2026-2030.
25. Feng, C.Y., Q.T. Li, X.Y. Zhang, K. Dong, B.Y. Hu and X.K. Guo, 2009. Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira. Braz. J. Med. Biol. Res., 42: 796-803.
26. Gamage, C.D., N. Koizumi, A.K. Perera, M. Muto and C. Nwafor-Okoli et al., 2012. Carrier status of leptospirosis among cattle in Sri Lanka: A zoonotic threat to public health. Transbound Emerg. Dis., 10.1111/tbed.12014
27. Gamberini, M., R.M. Gomez, M.V. Atzingen, E.A. Martins and S.A. Vasconcellos et al., 2005. Whole genome analysis of Leptospira interrogens to identify potential vaccine candidates against leptospirosis. FEMS Microbiol. Lett., 244: 305-313.
28. Gaynor, K., A.R. Katz, S.Y. Park, M. Nakata, T.A. Clark and P.V. Effler, 2007. Leptospirosis on Oahu: An outbreak associated with flooding of a university campus. Am. J. Trop. Med. Hyg., 76: 882-885.
29. Gebriel, A.M., G. Subramaniam and S.D. Sekaran, 2006. The detection and characterization of pathogenic Leptospira and the use of OMPs as potential antigens and immunogens. Trop. Biomed., 23: 194-207.
30. Goldstein, R.E., R.C. Lin, C.E. Lanstron, P.V. Scrivani, H.N. Erb and S.C. Barr, 2006. Influences of infecting serogroup on clinical features of leptospirosis in dogs. J. Vet. Intern. Med., 20: 489-494.
31. Gordon, P.J., 2002. Control of leptospirosis by vaccination. Vet. Rec., 150: 420-420.
32. Grassmann, A.A., S.R. Felix, C.X. dos Santos, M.G. Amaral and A.C. Seixas Neto et al., 2012. Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin. Vaccine Immunol., 19: 740-745.
33. Green-McKenzie, J. and W.H. Shoff, 2010. Leptospirosis in humans. eMedicine. http://emedicine.medscape.com/article/788751-overview.
34. Gulati, S. and A. Gulati, 2012. Pulmonary manifestations of leptospirosis. Lung India, 29: 347-353.
35. Hamond, C., G. Martins, R. Lawson-Ferreira, M.A. Medeiros and W. Lilenbaum, 2013. The role of horses in the transmission of leptospirosis in an urban tropical area. Epidemiol. Infect, 141: 33-35.
36. Hartskeerl R.A., M. Collares-Pereira and W.A. Ellis, 2011. Emergence, control and re-emerging leptospirosis: Dynamics of infection in the changing world. Clin. Microbiol. Infect, 17: 494-501.
37. He, H.J., W.Y. Wang, Z.D. Wu, Z.Y. Lv, J. Li and L.Z. Tan, 2008. Protection of guinea pigs against Leptospira interrogans serovar Lai by LipL21 DNA vaccine. Cell. Mol. Immunol., 5: 385-391.
38. Humphryes, P.C., M.E. Weeks, A. Gielbert, G. Thomson and N.G. Coldham, 2012. Analysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency. Clin. Vaccine Immunol., 19: 587-593.
39. Ko, A.I., C. Goarant and M. Picardeau, 2009. Leptospira: The dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol., 7: 736-747.
40. Koizumi, N. and H. Watanabe, 2003. Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain. FEMS Microbiol. Lett., 226: 215-219.
41. Koizumi, N. and H. Watanabe, 2003. Identification of a novel antigen of pathogenic Leptospira spp. that reacted with convalescent mice sera. J. Med. Microbiol., 52: 585-589.
42. Koizumi, N. and H. Watanabe, 2005. Leptospira vaccines: Past, present and future. J. Postgrad Med., 51: 210-214.
43. Koizumi, N. and I. Yasutomi, 2012. Prevalence of leptospirosis in farm animals. Jpn. J. Vet. Res., 60: S55-S58.
44. Koizumi, N., C. Nakajima, T. Harunari, T. Tanikawa and T. Tokiwa et al., 2012. A new loop-mediated isothermal amplification method for rapid, simple and sensitive detection of Leptospira spp. in urine. J. Clin. Microbiol., 50: 2072-2074.
45. Koma, T., K. Yoshimatsu, S.P. Yasuda, T. Li and T. Amada et al., 2012. A survey of rodent-borne pathogens carried by wild Rattus spp. in Northern Vietnam. Epidemiol. Infect, 1: 1-9.
46. Kulpa-Eddy, J., 2012. Successful development and validation of an in vitro replacement assay for Leptospira vaccine potency tests. Dev. Biol. (Basel), 134: 101-106.
47. Lau, C.L., C. Skelly, L.D. Smythe, S.B. Craig and P. Weinstein, 2012. Emergence of new leptospiral serovars in American Samoa-ascertainment or ecological change? BMC Infect. Dis., Vol. 12. 10.1186/1471-2334-12-19
48. Levett, P.N. and D. Haake, 2012. Leptospira species (Leptospirosis). Elsevier, Japan, Pages: 5, http://www.elsevierjapan.com/Portals/0/images/pdf/Chapter%20240.pdf
49. Levett, P.N., 2003. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin. Infect. Dis., 36: 447-452.
50. Lim, V.K., 2011. Leptospirosis: A re-emerging infection. Malays. J. Pathol., 33: 1-5.
51. Luo, D., F. Xue, D.M. Ojcius, J. Zhao and Y. Mao et al., 2009. Protein typing of major outer membrane lipoproteins from Chinese pathogenicLeptospira spp. and characterization of their immunogenicity. Vaccine, 28: 243-255.
52. Lutticken, D., R.P. Segers and N. Visser, 2007. Veterinary vaccines for public health and prevention of viral and bacterial zoonotic diseases. Rev. Sci. Tech., 26: 165-177.
53. Mahima, A.K. Verma, A. Kumar, A. Rahal and V. Kumar, 2012. Veterinarian for sustainable development of humanity. Asian J. Anim. Vet. Adv., 7: 452-453.
54. Maneewatch, S., P. Tapchaisri, Y. Sakolvaree, B. Klaysing and P. Tongtawe et al., 2007. OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge. Asian Pac. J. Allergy Immunol., 25: 75-82.
55. Martinez, R., A. Perez, C. Quinones Mdel, R. Cruz and A. Alvarez et al., 2004. Efficacy and safety of a vaccine against human leptospirosis in Cuba. Rev. Panam. Salud. Publica., 15: 249-255.
56. Matsunaga, J., T.A. Young, J.K. Barnett, D. Barnett, C.A. Bolin and D.A. Haake, 2002. Novel 45-kilodalton leptospiral protein that is processed to a 31-kilodalton growth-phase-regulated peripheral membrane protein. Infect. Immun., 70: 323-334.
57. Matsuo, K., E. Isogai and Y. Araki, 2000. Control of immunologically crossreactive leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa. Microbiol. Immunol., 44: 887-890.
58. McBride A.J., D.A. Athanazio, M.G. Reis and A.I. Ko, 2005. Leptospirosis. Curr. Opin. Infect. Dis., 18: 376-386.
59. Meykadeh, N., A. Mirmohammadsadegh, Z. Wang, E. Basner-Tschakarjan and U.R. Hengge, 2005. Topical application of plasmid DNA to mouse and human skin. J. Mol. Med., 83: 897-903.
60. Muhldorfer, K., 2012. Bats and bacterial pathogens: A review. Zoonoses Public Health, 10.1111/j.1863-2378.2012.01536. x
61. Murray, G.L., 2012. The lipoprotein LipL32, an enigma of leptospiral biology. Vet. Microbiol.
62. Murray, G.L., M. Lo, D.M. Bulach, A. Srikram, T. Seemann et al., 2012. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonization. Vaccine, 31: 495-499.
63. Nafeev, A.A., G.V. Salina and V.A. Nikishin, 2012. Zoonoses as occupational diseases. Med. Tru. Prom. Ekol., 2012: 1-4.
64. Nascimento A.L., A.I. Ko, E.A. Martins, C.B. Monteiro-Vitorelloans P.L. Ho et al., 2004. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J. Bacteriol., 186: 2164-2172.
65. Palaniappan, R.U.M., S.P. McDonough, T.J. Divers, C.S. Chen, M.J. Pan, M. Matsumoto and Y.F. Chang, 2006. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect. Immunity, 74: 1745-1750.
66. Philip, N.A. and R.B. Tennent, 1966. Leptospirosis: A report from one practice on the use of a leptospiral vaccine for a period of three years. N. Z. Med. J., 65: 13-19.
67. Picardeau, M., C. Le Dantec, G.F. Richard and I.S. Girons, 2003. The spirochetal chpK-chromosomal toxin-antitoxin locus induces growth inhibition of yeast and mycobacteria. FEMS Microbiol. Lett., 229: 277-281.
68. Pradhan, S., R. Tandon and J. Kishore, 2012. Combined involvement of muscle, nerve and myoneural junction following Leptospira infection. Neurol. India, 60: 514-516.
69. Puliyath, G. and S. Singh, 2012. Leptospirosis in pregnancy. Eur. J. Clin. Microbiol. Infect. Dis., 31: 2491-2496.
70. Rinehart, C.L., A.D. Zimmerman, R.E. Buterbaugh, R.A. Jolie and C.C.L. Chase, 2012. Efficacy of vaccination of cattle with the Leptospira interrogans serovar hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge withLeptospira borgpetersenii serovar hardjo type hardjo-bovis. Am. J. Vet. Res., 73: 735-740.
71. Seixas, F.K., C.H. Fernandes, D.D. Hartwig, F.R. Conceicao, J.A.G. Aleixo and O.A. Dellagostin, 2007. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can. J. Microbiol., 53: 472-479.
72. Serruto, D., J. Adu-Bobie, B. Capeechi, R. Rappuoli, M. Pizza and V. Masignani, 2004. Biotechnology and vaccines: Application of functional genomics to Neisseria meningitidis and other bacterial pathogens. J. Biotechnol., 113: 15-32.
73. Signorini, M.L., J. Lottersberger, H.D. Tarabla and N.B. Vanasco, 2013. Enzyme-linked immunosorbent assay to diagnose human leptospirosis: A meta-analysis of the published literature. Epidemiol. Infect., 141: 22-32.
74. Silva, E.F., M.A. Medeiros, A.J.A. McBride, J. Matsunaga and G.S. Esteves et al., 2007. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine, 25: 6277-6286.
75. Silva, J., D. Leite, M. Fernandes, C. Mena, P.A. Gibbs and P. Teixeira, 2011. Campylobacter spp. as a foodborne pathogen: A review. Front. Microbiol., Vol. 2. 10.3389/fmicb.2011.00200
76. Smith, J.K., M.M. Young, K.L. Wilson and S.B. Craig, 2012. Leptospirosis following a major flood in Central Queensland, Australia. Epidemiol. Infect., (In Press). 10.1017/S0950268812001021
77. Smythe, L., B. Adler, R.A. Hartskeerl, R.L. Galloway, C.Y. Turenne and P.N. Levett, 2012. Classification of Leptospira genomospecies 1, genomospecies 3, genomospecies 4 and genomospecies 5 as Leptospira alstonii sp. nov., Leptospira vanthielii sp. nov., Leptospira terpstrae sp. nov., Leptospira yanagawae sp. nov., respectively. Int. J. Syst. Evol. Microbiol., (In Press). 10.1099/ijs.0.047324-0
78. Srikram, A., K. Zhang, T. Bartpho, M. Lo and D.E. Hoke et al., 2011. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J. Infect. Dis., 203: 870-879.
79. Srivastava, S.K., 2006. Prospects of developing leptospiral vaccines for animals. Indian J. Med. Microbiol., 24: 331-336.
80. Stoddard, R.A., 2013. Detection of Pathogenic Leptospira spp. through Real-Time PCR (qPCR) Targeting the LipL32 Gene. In: PCR Detection of Microbial Pathogens, Wilks, M. (Ed.). Springer, New York, USA., ISBN-13: 9781603273527, pp: 257-266.
81. Suwancharoen, D., C. Kulchim, C. Chirathaworn and S. Yoshida, 2012. Development of a novel primer combination to detect pathogenicLeptospira by loop-mediated isothermal amplification. J. Microbiol. Methods, 91: 171-173.
82. Tanganuchitcharnchai, A., L. Smythe, M. Dohnt, R. Hartskeerl and M. Vongsouvath et al., 2012. Evaluation of the standard diagnosticsLeptospira IgM ELISA for diagnosis of acute leptospirosis in Lao PDR. Trans. R. Soc. Trop. Med. Hygiene, 106: 563-566.
83. Thongboonkerd, V., 2008. Proteomics in leptospirosis research: Towards molecular diagnostics and vaccine development. Expert Rev. Mol. Diagn., 8: 53-61.
84. Tulsiani, S.M., G.C. Graham, M.F. Dohnt, M.A. Burns and S.B. Craig, 2011. Maximizing the chances of detecting pathogenic leptospires in mammals: The evaluation of field samples and a multi-sample-per-mammal, multi-test approach. Ann. Trop. Med. Parasitol., 105: 145-162.
85. Umamaheswari, A., D. Pradhan and M. Hemanthkumar, 2012. Computer aided subunit vaccine design against pathogenic Leptospiraserovars. Interdisciplin. Sci.: Comput. Life Sci., 4: 38-45.
86. Vedhagiri, K., K. Natarajaseenivasan, P. Chellapandi, S.G. Prabhakaran, J. Selvin, S. Sharma and P. Vijayachari, 2009. Evolutionary implication of outer membrane lipoprotein-encoding genes ompL1, ompL32 and lipL41 of pathogenic Leptospira species. Genomics Proteom. Bioinform., 7: 96-106.
87. Villumsen, S., R. Pedersen, M.B. Borre, P. Ahrens, J.S. Jensen and K.A. Krogfelt, 2012. Novel TaqMan® PCR for detection of Leptospiraspecies in urine and blood: Pit-falls of in silico validation. J. Microbiol. Methods, 91: 184-190.
88. WHO-ILS, 2003. Human leptospirosis: Guidance for diagnosis, surveillance and control. http://whqlibdoc.who.int/hq/2003/WHO_CDS_CSR_EPH_2002.23.pdf.
89. Wallace, R.L., 2005. Lepto hardjo and reproductive losses. http://www.traill.uiuc.edu/dairynet/.
90. Wang, Z., L. Jin and A. Wegrzyn, 2007. Leptospirosis vaccines. Microb. Cell Factories, Vol. 6. 10.1186/1475-2859-6-39
91. Wang, Z., Z. Yuan and U.R. Hengge, 2004. Processing of plasmid DNA with ColE1-like replication origin. Plasmid, 51: 149-161.
92. Yang, H.L., Y.Z. Zhu, J.H. Qin, P. He, X.C. Jiang, G.P. Zhao and X.K. Guo, 2006. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira Interrogans. BMC Genomics, 7: 293-293.
93. Zuerner, R.L., D.P. Alt, M.V. Palmer, T.C. Thacker and S.C. Olsen, 2011. A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells and reduces renal colonization. Clin. Vaccine Immunol., 18: 684-691.